We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.41%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$67.1B
AUM Growth
-$1.4B
(-2%)
Cap. Flow
+$2.19B
Cap. Flow
% of AUM
3.26%
Top 10 Holdings %
Top 10 Hldgs %
22.03%
Holding
3,122
New
29
Increased
2,768
Reduced
217
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$146M |
| 2 |
Apple
AAPL
|
+$75.7M |
| 3 |
Tesla
TSLA
|
+$70.4M |
| 4 |
Amazon
AMZN
|
+$65M |
| 5 |
Procter & Gamble
PG
|
+$55.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACC
American Campus Communities, Inc.
ACC
|
+$27.2M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$21.1M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$19.2M |
| 4 |
COHR
Coherent Inc
COHR
|
+$18.8M |
| 5 |
SAIL
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.62% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRG
2226
Seritage Growth Properties
SRG
$136M
| $860K | ﹤0.01% |
95,298
-4,302
| -4% | -$49.2K |
|
2227
Janus International
JBI
$757M
| $858K | ﹤0.01% |
96,218
+7,302
| +8% | +$74K |
|
2228
OraSure Technologies
OSUR
$279M
| $856K | ﹤0.01% |
225,903
+8,992
| +4% | +$32.5K |
|
2229
Arcutis Biotherapeutics
ARQT
$3.18B
| $854K | ﹤0.01% |
44,674
+3,329
| +8% | +$75.4K |
|
2230
Comtech Telecommunications
CMTL
$51.8M
| $854K | ﹤0.01% |
85,276
+5,062
| +6% | +$55.8K |
|
2231
National Presto Industries
NPK
$989M
| $852K | ﹤0.01% |
13,101
+420
| +3% | +$29.1K |
|
2232
Great Southern Bancorp
GSBC
$878M
| $848K | ﹤0.01% |
14,859
+789
| +6% | +$47.6K |
|
|
DAWN
2233
DELISTED
Day One Biopharmaceuticals
DAWN
| $846K | ﹤0.01% |
42,242
+8,288
| +24% | +$176K |
|
2234
Solid Power
SLDP
$532M
| $841K | ﹤0.01% |
159,948
+83,442
| +109% | +$527K |
|
2235
Yum China
YUMC
$16.3B
| $840K | ﹤0.01% |
17,745
-2,010
| -10% | -$96.5K |
|
|
CATC
2236
DELISTED
CAMBRIDGE BANCORP
CATC
| $840K | ﹤0.01% |
10,537
+636
| +6% | +$52.3K |
|
2237
Phibro Animal Health
PAHC
$1.39B
| $839K | ﹤0.01% |
63,134
+1,919
| +3% | +$33.1K |
|
|
TSVT
2238
DELISTED
2seventy bio
TSVT
| $837K | ﹤0.01% |
57,548
+3,246
| +6% | +$48.2K |
|
2239
Oil States International
OIS
$491M
| $836K | ﹤0.01% |
214,834
+9,281
| +5% | +$44.3K |
|
2240
Bionano Genomics
BNGO
$13.3M
| $835K | ﹤0.01% |
760
+61
| +9% | +$80.6K |
|
|
RAPT
2241
DELISTED
RAPT Therapeutics
RAPT
| $835K | ﹤0.01% |
4,336
+331
| +8% | +$62.6K |
|
2242
Old Second Bancorp
OSBC
$1.29B
| $834K | ﹤0.01% |
63,903
+3,518
| +6% | +$49.4K |
|
2243
AnaptysBio
ANAB
$1.68B
| $832K | ﹤0.01% |
32,632
+2,035
| +7% | +$47.7K |
|
|
MRC
2244
DELISTED
MRC Global
MRC
| $828K | ﹤0.01% |
115,190
+10,843
| +10% | +$107K |
|
|
CTIC
2245
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $826K | ﹤0.01% |
141,915
+15,381
| +12% | +$95.9K |
|
2246
Gevo
GEVO
$382M
| $825K | ﹤0.01% |
361,644
+17,239
| +5% | +$48.1K |
|
2247
Sana Biotechnology
SANA
$980M
| $825K | ﹤0.01% |
137,562
+7,543
| +6% | +$54.4K |
|
2248
First Financial Corp
THFF
$969M
| $824K | ﹤0.01% |
18,242
+908
| +5% | +$41.9K |
|
2249
Alphatec Holdings
ATEC
$1.44B
| $823K | ﹤0.01% |
94,194
+7,257
| +8% | +$57.4K |
|
2250
MaxCyte
MXCT
$126M
| $823K | ﹤0.01% |
126,587
+7,403
| +6% | +$41.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, RhumbLine Advisers held 3,122 positions worth $67.1B, down 2% from $68.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2.19B of net new capital in Q3 2022, opening 29 new positions and adding to 2,768 existing holdings. Its largest new stake was Enhabit: 136,327 shares worth $1.91M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $21.1M trimmed.
- RhumbLine Advisers's largest Q3 2022 buy was Enhabit: 136,327 shares worth $1.91M.
- RhumbLine Advisers added most to Microsoft in Q3 2022, an estimated $146M increase.
- RhumbLine Advisers's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21.1M.
- RhumbLine Advisers fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $27.2M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $67.1B portfolio in Q3 2022.
- RhumbLine Advisers opened 29 new positions and closed 40 in Q3 2022.
- RhumbLine Advisers's portfolio value fell 2% quarter-over-quarter to $67.1B.
Based on RhumbLine Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.